Catalyst Wire Dossier Catalyst Wire Dossier

Stilvid

Resveratrol-enriched grape extract · National Research Council, Spain
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Stilvid, covering 2011-11-16 to 2011-11-16. Get the full timeline:

Most recent: Clinical Trial Update: Resveratrol-enriched Grape Extract (Stilvid) in Primary and Secondary Prevention of Cardiovascular Disease [Phase 2]

See pricing